Full Text View
Tabular View
No Study Results Posted
Related Studies
Levofloxacin Pharmacokinetics (PK) in the Severely Obese
This study has been completed.
Study NCT00176306   Information provided by University of Kentucky
First Received: September 12, 2005   Last Updated: February 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity
Critical Illness
More general conditions related to this trial
Body Weight
Disease Attributes
Nutrition Disorders
Overnutrition
Overweight
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
Levofloxacin 750 mg IV
Additional drug interventions recognized in this trial
Ofloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
University of Kentucky
Ortho-McNeil Pharmaceutical
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services